{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:42:49Z","timestamp":1795084969923,"version":"4.10.2"},"reference-count":70,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,2,13]],"date-time":"2009-02-13T00:00:00Z","timestamp":1234483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    The diagnosis of disseminated intravascular coagulation (DIC) should encompass both clinical and laboratory information. The International Society for Thrombosis and Haemostasis (ISTH) DIC scoring system provides objective measurement of DIC. Where DIC is present the scoring system correlates with key clinical observations and outcomes. It is important to repeat the tests to monitor the dynamically changing scenario based on laboratory results and clinical observations. The cornerstone of the treatment of DIC is treatment of the underlying condition. Transfusion of platelets or plasma (components) in patients with DIC should not primarily be based on laboratory results and should in general be reserved for patients who present with bleeding. In patients with DIC and bleeding or at high risk of bleeding (e.g. postoperative patients or patients due to undergo an invasive procedure) and a platelet count of &lt;50\u2003\u00d7\u200310\n                    <jats:sup>9<\/jats:sup>\n                    \/l transfusion of platelets should be considered. In non\u2010bleeding patients with DIC, prophylactic platelet transfusion is not given unless it is perceived that there is a high risk of bleeding. In bleeding patients with DIC and prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), administration of fresh frozen plasma (FFP) may be useful. It should not be instituted based on laboratory tests alone but should be considered in those with active bleeding and in those requiring an invasive procedure. There is no evidence that infusion of plasma stimulates the ongoing activation of coagulation. If transfusion of FFP is not possible in patients with bleeding because of fluid overload, consider using factor concentrates such as prothrombin complex concentrate, recognising that these will only partially correct the defect because they contain only selected factors, whereas in DIC there is a global deficiency of coagulation factors. Severe hypofibrinogenaemia (&lt;1\u2003g\/l) that persists despite FFP replacement may be treated with fibrinogen concentrate or cryoprecipitate. In cases of DIC where thrombosis predominates, such as arterial or venous thromboembolism, severe purpura fulminans associated with acral ischemia or vascular skin infarction, therapeutic doses of heparin should be considered. In these patients where there is perceived to be a co\u2010existing high risk of bleeding there may be benefits in using continuous infusion unfractionated heparin (UFH) due to its short half\u2010life and reversibility. Weight adjusted doses (e.g. 10\u2003\u03bc\/kg\/h) may be used without the intention of prolonging the APTT ratio to 1\u00b75\u20132\u00b75 times the control. Monitoring the APTT in these cases may be complicated and clinical observation for signs of bleeding is important. In critically ill, non\u2010bleeding patients with DIC, prophylaxis for venous thromboembolism with prophylactic doses of heparin or low molecular weight heparin is recommended. Consider treating patients with severe sepsis and DIC with recombinant human activated protein C (continuous infusion, 24\u2003\u03bcg\/kg\/h for 4\u2003d). Patients at high risk of bleeding should not be given recombinant human activated protein C. Current manufacturers guidance advises against using this product in patients with platelet counts of &lt;30\u2003\u00d7\u200310\n                    <jats:sup>9<\/jats:sup>\n                    \/l. In the event of invasive procedures, administration of recombinant human activated protein C should be discontinued shortly before the intervention (elimination half\u2010life \u224820\u2003min) and may be resumed a few hours later, dependent on the clinical situation. In the absence of further prospective evidence from randomised controlled trials confirming a beneficial effect of antithrombin concentrate on clinically relevant endpoints in patients with DIC and not receiving heparin, administration of antithrombin cannot be recommended. In general, patients with DIC should not be treated with antifibrinolytic agents. Patients with DIC that is characterised by a primary hyperfibrinolytic state and who present with severe bleeding could be treated with lysine analogues, such as tranexamic acid (e.g. 1\u2003g every 8\u2003h).\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2141.2009.07600.x","type":"journal-article","created":{"date-parts":[[2009,2,13]],"date-time":"2009-02-13T00:58:57Z","timestamp":1234486737000},"page":"24-33","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":938,"title":["Guidelines for the diagnosis and management of disseminated intravascular coagulation"],"prefix":"10.1111","volume":"145","author":[{"given":"M","family":"Levi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. H.","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Thachil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. G.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,3,10]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200111000-00007"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.2.238"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050935"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200204000-00005"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1651366"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000196832.27501.B2"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2001.5790508.x"},{"key":"e_1_2_7_9_1","first-page":"147","article-title":"Use of a low molecular weight heparin, CY 222, in the treatment of consumption coagulopathy","volume":"12","author":"Audibert G.","year":"1987","journal-title":"Journal des Maladies Vasculaires"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90181-5"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000147769.07699.E3"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103083441001"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc2167"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.125.6.2206"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-998993"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(92)90116-R"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0268-960X(90)90014-J"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02270-8.x"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/91.3.280"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20597"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06281.x"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.8.12.5588"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2005.09.005"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197010082831502"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc3774"},{"key":"e_1_2_7_26_1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1055\/s-0037-1616052","article-title":"The fibrin assay comparison trial (FACT): correlation of soluble fibrin assays with D\u2010dimer","volume":"86","author":"Dempfle C.E.","year":"2001","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"e_1_2_7_27_1","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1160\/TH03-09-0577","article-title":"Use of soluble fibrin antigen instead of D\u2010dimer as fibrin\u2010related marker may enhance the prognostic power of the ISTH overt DIC score","volume":"91","author":"Dempfle C.E.","year":"2004","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000110678.52863.F3"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00955.x"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.1062972.x"},{"key":"e_1_2_7_31_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-0037-1615140","article-title":"Early identification and prognostic implications in disseminated intravascular coagulation through transmittance waveform analysis","volume":"80","author":"Downey C.","year":"1998","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200108093450603"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1002795"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.101.3.816"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/107602960501100108"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-18870"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01697.x"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04790.x"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2005.02.001"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc4975"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908193410807"},{"key":"e_1_2_7_42_1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1055\/s-0037-1615899","article-title":"Disseminated intravascular coagulation","volume":"82","author":"Levi M.","year":"1999","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200612-1803OC"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04256.x"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra067742"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)90225-0"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1177\/107602960601200206"},{"key":"e_1_2_7_48_1","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1055\/s-0037-1614905","article-title":"Reactivity of soluble fibrin assays with plasmic degradation products of fibrin and in patients receiving fibrinolytic therapy","volume":"82","author":"McCarron B.I.","year":"1999","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.3.881.881"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199207000-00007"},{"key":"e_1_2_7_51_1","first-page":"90","article-title":"Enhanced fibrinolytic activity during the course of hemodialysis","volume":"38","author":"Nakamura Y.","year":"1992","journal-title":"Clinical Nephrology"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V56.1.88.88"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-198906000-00007"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2005.09.014"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.25.2485"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(89)90239-9"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909093411103"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-100669"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001340050817"},{"key":"e_1_2_7_60_1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1055\/s-0038-1646662","article-title":"Clinical and laboratory aspects of disseminated intravascular coagulation (DIC): a study of 118 cases","volume":"39","author":"Siegal T.","year":"1978","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-005-2685-2"},{"key":"e_1_2_7_62_1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-0038-1650005","article-title":"Disseminated intravascular coagulation. Findings in 346 patients","volume":"43","author":"Spero J.A.","year":"1980","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112902"},{"key":"e_1_2_7_64_1","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor F.B.","year":"2001","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7421.974"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02313.x"},{"key":"e_1_2_7_67_1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1055\/s-0037-1614055","article-title":"Thromboplastin sensitivity in waveform analysis","volume":"84","author":"Toh C.H.","year":"2000","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"e_1_2_7_68_1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1055\/s-0038-1649835","article-title":"Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group","volume":"74","author":"Wada H.","year":"1995","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.15.1869"},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1989.tb06276.x"},{"key":"e_1_2_7_71_1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1055\/s-0038-1653469","article-title":"Comparison of thrombelastography with common coagulation tests","volume":"46","author":"Zuckerman L.","year":"1981","journal-title":"Journal of Thrombosis and Haemostasis"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2009.07600.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2009.07600.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T12:13:59Z","timestamp":1695903239000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2009.07600.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,10]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1111\/j.1365-2141.2009.07600.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2009.07600.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,10]]},"assertion":[{"value":"2009-03-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}